Banner Image Banner Image

Event Details

Home / Investors / Events & Presentations/

Effect of Plozasiran Targeting APOC3 on Lipoprotein Particle Number and Size Measured by NMR in P...

Effect of Plozasiran Targeting APOC3 on Lipoprotein Particle Number and Size Measured by NMR in Patients with Hypertriglyceridemia

Mar 29, 2025 9:54 AM CDT

Presenter: Christie M. Ballantyne, MD

Session: Session 901: Basic and Translational Discovery and Innovations in Cardiovascular Disease Prevention

Type: Moderated Poster

Supporting Materials